Clinical efficacy of BG-12, an oral therapy, in relapsing-remitting multiple sclerosis: data from the phase 3 DEFINE trialR. Gold,L. Kappos, A. Bar-Or,D. Arnold,G. Giovannoni,K. Selmaj,M. Yang,K. DawsonMULTIPLE SCLEROSIS JOURNAL（2011）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
